Compare QTRX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | TKNO |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 138.1M |
| IPO Year | 2017 | 2021 |
| Metric | QTRX | TKNO |
|---|---|---|
| Price | $3.37 | $3.58 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 877.3K | 98.3K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | $37,632,000.00 | ★ $40,520,000.00 |
| Revenue This Year | $25.49 | $8.27 |
| Revenue Next Year | $10.04 | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 64.52 | 7.35 |
| 52 Week Low | $2.95 | $1.91 |
| 52 Week High | $8.77 | $7.48 |
| Indicator | QTRX | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 44.04 | 65.07 |
| Support Level | $3.30 | $3.60 |
| Resistance Level | $3.81 | $4.26 |
| Average True Range (ATR) | 0.24 | 0.25 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 54.25 | 97.41 |
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.